<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36158939</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>08</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1937-8688</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>Suppl 1</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>The Pan African medical journal</Title><ISOAbbreviation>Pan Afr Med J</ISOAbbreviation></Journal><ArticleTitle>Polio eradication in a chronic conflict setting lessons from the Republic of South Sudan, 2010-2020.</ArticleTitle><Pagination><StartPage>3</StartPage><MedlinePgn>3</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">3</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.11604/pamj.supp.2022.42.1.32922</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">in 1988 the World Health Assembly set an ambitious target to eradicate Wild Polio Virus (WPV) by 2000, following the successful eradication of the smallpox virus in 1980. South Sudan and the entire African region were certified WPV free on August 25, 2020. South Sudan has maintained its WPV free status since 2010, and this paper reviewed the country's progress, outlined lessons learned, and describes the remaining challenges in polio eradication.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">secondary data analysis was conducted using the Ministry of Health and WHO polio surveillance datasets, routine immunisation coverage, polio campaign data, and surveys from 2010 to 2020. Relevant technical documents and reports on polio immunisation and surveillance were also reviewed. Data analysis was conducted using EPI Info 7 software.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">administrative routine immunisation coverage for bivalent Oral Polio Vaccine (OPV) 3rd dose declined from 77% in 2010 to 56% in 2020. In contrast, the administrative and post-campaign evaluation coverage recorded for the nationwide supplemental polio campaigns since 2011 was consistently above 85%; however, campaigns declined in number from four in 2011 to zero in 2020. Overall, 76% of notified cases of Acute Flaccid Paralysis (AFP) received three or more doses of the oral polio vaccine. The Annualized Non-AFP rate ranged between 4.0 to 5.4 per 100,000 under 15 years populations, and stool adequacy ranged from 83% to 94%.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">South Sudan's polio-free status documentation was accepted by the ARCC in 2020, thereby enabling the African Region to be certified WPV free on August 25, 2020. However, there are concerns as the country continues to report low routine immunisation coverage and a reduction in the number of polio campaigns conducted each year. It is recommended that the country conduct high-quality nationwide supplemental polio campaigns yearly to achieve and maintain the required herd immunity. It invests in its routine immunisation program while ensuring optimal AFP surveillance performance indicators.</AbstractText><CopyrightInformation>©Sylvester Maleghemi et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Maleghemi</LastName><ForeName>Sylvester</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>World Health Organization, WHO Country Office, Ministerial Complex, Juba, South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tegegne</LastName><ForeName>Ayesheshem Ademe</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>World Health Organization, WHO Country Office, Ministerial Complex, Juba, South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferede</LastName><ForeName>Melisachew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>World Health Organization, WHO Country Office, Ministerial Complex, Juba, South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bassey</LastName><ForeName>Bassey Enya</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>World Health Organization Oyo State Office, Nigeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akpan</LastName><ForeName>Godwin Ubong</ForeName><Initials>GU</Initials><AffiliationInfo><Affiliation>World Health Organization, Regional Office for Africa, Cite de Djoue, Brazzaville, Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bello</LastName><ForeName>Isah Mohammed</ForeName><Initials>IM</Initials><AffiliationInfo><Affiliation>World Health Organization, Inter-Country Support Team office for East and Southern Africa, P.O. Box 5160, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ticha</LastName><ForeName>Johnson Muluh</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>World Health Organization, Regional Office for Africa, Cite de Djoue, Brazzaville, Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anyuon</LastName><ForeName>Atem</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Ministry of Health, Ministerial Complex, Juba, South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Waya</LastName><ForeName>Joy Luba</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>World Health Organization, WHO Country Office, Ministerial Complex, Juba, South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okiror</LastName><ForeName>Samuel Oumo</ForeName><Initials>SO</Initials><AffiliationInfo><Affiliation>World Health Organization, Regional Office for Africa, Cite de Djoue, Brazzaville, Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ndoutabe</LastName><ForeName>Modjirom</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>World Health Organization, Regional Office for Africa, Cite de Djoue, Brazzaville, Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berta</LastName><ForeName>Kibebu Kinfu</ForeName><Initials>KK</Initials><AffiliationInfo><Affiliation>World Health Organization, WHO Country Office, Ministerial Complex, Juba, South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ndenzako</LastName><ForeName>Fabian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>World Health Organization, WHO Country Office, Ministerial Complex, Juba, South Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mkanda</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>World Health Organization, Regional Office for Africa, Cite de Djoue, Brazzaville, Congo.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olu</LastName><ForeName>Olushayo Oluseun</ForeName><Initials>OO</Initials><AffiliationInfo><Affiliation>World Health Organization, WHO Country Office, Ministerial Complex, Juba, South Sudan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>001</GrantID><Acronym>WHO_</Acronym><Agency>World Health Organization</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Uganda</Country><MedlineTA>Pan Afr Med J</MedlineTA><NlmUniqueID>101517926</NlmUniqueID></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011055">Poliovirus Vaccine, Oral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D060740" MajorTopicYN="N">Disease Eradication</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017589" MajorTopicYN="N">Immunization Programs</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011051" MajorTopicYN="Y">Poliomyelitis</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017955" MajorTopicYN="Y">Poliovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011055" MajorTopicYN="N">Poliovirus Vaccine, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="N">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000068037" MajorTopicYN="N" Type="Geographic">South Sudan</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Polio eradication</Keyword><Keyword MajorTopicYN="N">South Sudan</Keyword><Keyword MajorTopicYN="N">acute flaccid paralysis</Keyword><Keyword MajorTopicYN="N">polio campaigns</Keyword><Keyword MajorTopicYN="N">routine immunisation coverage</Keyword><Keyword MajorTopicYN="N">wild poliovirus</Keyword><Keyword MajorTopicYN="N">wild poliovirus free certification</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>4</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>26</Day><Hour>17</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36158939</ArticleId><ArticleId IdType="pmc">PMC9474935</ArticleId><ArticleId IdType="doi">10.11604/pamj.supp.2022.42.1.32922</ArticleId><ArticleId IdType="pii">PAMJ-SUPP-42-1-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization Poliomyelitis. Accessed December 5, 2021.</Citation></Reference><Reference><Citation>World Health Organization The immunological basis for immunisation series. 2019.</Citation></Reference><Reference><Citation>Lien G, Heymann DL. The problems with polio: toward eradication. Infect Dis Ther. 2013 Dec;2(2):167–174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4108111</ArticleId><ArticleId IdType="pubmed">25134479</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Seventieth world health assembly update 25 May. Accessed December 5, 2021.</Citation></Reference><Reference><Citation>Centre for Public Impact The Global polio eradication initiative (GPEI) 2016. Accessed December 5, 2021.</Citation></Reference><Reference><Citation>Bassey BE, Vaz RG, Braka F, Komakech W, Maleghemi ST, Akpan GU, et al. Profiling the immunity status of children with non-polio acute flaccid paralysis who had not received any doses of oral polio vaccine in the South-South region, Nigeria 2011-2014. Public Health. 2016 Oct;139:148–153.</Citation><ArticleIdList><ArticleId IdType="pubmed">27302057</ArticleId></ArticleIdList></Reference><Reference><Citation>Maleghemi S, Enya Bassey B, George B, Usman A, Anthony K, Bassey E. Improving Acute Flaccid Paralysis (AFP) surveillance performance in South Sudan: the contribution of open data kit mobile data collection technology. Am J Epidemiol Infect Dis. 2019;7(1):11–15.</Citation></Reference><Reference><Citation>Dattani S, Spooner F, Ochmann S, Roser M. Our world in data. Polio. 2017. Accessed December 5, 2021.</Citation></Reference><Reference><Citation>Aylward RB, Hull HF, Cochi SL, Sutter RW, Olivé JM, Melgaard B. Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bull World Health Organ. 2000;78(3):285–97.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2560720</ArticleId><ArticleId IdType="pubmed">10812724</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative Global wild poliovirus analysis 2015-2020. Accessed December 5 2021.</Citation></Reference><Reference><Citation>Greene SA, Ahmed J, Datta SD, Burns CC, Quddus A, Vertefeuille JF, et al. Progress toward polio eradication-worldwide, January 2017-March 2019. MMWR Morb Mortal Wkly Rep. 2019 May 24;68(20):458–462.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6532951</ArticleId><ArticleId IdType="pubmed">31120868</ArticleId></ArticleIdList></Reference><Reference><Citation>Moffett DB, Llewellyn A, Singh H, Saxentoff E, Partridge J, Iakovenko M, et al. Progress toward poliovirus containment implementation-worldwide, 2018-2019. MMWR Morb Mortal Wkly Rep. 2019 Sep 27;68(38):825–829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6762185</ArticleId><ArticleId IdType="pubmed">31557146</ArticleId></ArticleIdList></Reference><Reference><Citation>Global polio eradication initiative . 2019. Two out of three wild poliovirus strains eradicated. Accessed March 8, 2020.</Citation></Reference><Reference><Citation>World Health Organization Global polio eradication initiative strategic plan 2004-2008 WHO partners in the global polio eradication initiative. 2003.</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative When could the Eastern Mediterranean Region be free of wild poliovirus? Accessed May 15 2020.</Citation></Reference><Reference><Citation>World Health Organization Statement of the twenty-third IHR emergency committee regarding the International spread of poliovirus. 2020. Accessed March 8, 2020.</Citation></Reference><Reference><Citation>World Health Organization-Nigeria Three years without a case of wild polio virus. Government of Nigeria warns against complacency. 2019. Aug 21, Accessed May 25, 2020.</Citation></Reference><Reference><Citation>WHO EMRO . Sudan: polio eradication initiative. Accessed May 15, 2020.</Citation></Reference><Reference><Citation>Global Polio Eradication Initiative South Sudan. Accessed December 6, 2021.</Citation></Reference><Reference><Citation>OCHA South Sudan. Accessed April 2, 2022.</Citation></Reference><Reference><Citation>The World Bank South Sudan household survey 2010. Accessed May 15, 2020.</Citation></Reference><Reference><Citation>International Crisis Group Toward a viable future for South Sudan. 2021. Accessed April 29, 2022.</Citation></Reference><Reference><Citation>Gardner TJ, Diop OM, Jorba J, Chavan S, Ahmed J, Anand A. Surveillance to track progress toward polio eradication-Worldwide, 2016-2017. MMWR Morb Mortal Wkly Rep. 2018 Apr 13;67(14):418–423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5898223</ArticleId><ArticleId IdType="pubmed">29649187</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Polio Eradication Initiative Surveillance Indicators. Accessed June 30, 2021.</Citation></Reference><Reference><Citation>Odoom JK, Ntim NAA, Sarkodie B, Addo J, Minta-Asare K, Obodai E, et al. Evaluation of AFP surveillance indicators in polio-free Ghana, 2009-2013. BMC Public Health. 2014 Jul 5;14:687.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4094438</ArticleId><ArticleId IdType="pubmed">24996415</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization Diphtheria tetanus toxoid and pertussis (DTP) vaccination coverage. 2021. Accessed April 29, 2022.</Citation></Reference><Reference><Citation>Tesfaye B, Sowe A, Kisangau N, Ogange J, Ntoburi S, Nekar I, et al. An epidemiological analysis of Acute Flaccid Paralysis (AFP) surveillance in Kenya, 2016 to 2018. BMC Infect Dis. 2020 Aug 18;20(1):611.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7437168</ArticleId><ArticleId IdType="pubmed">32811467</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Wijngaarden JDH, Scholten GRM, Van Wijk KP. Strategic analysis for health care organisations: the suitability of the SWOT-analysis. Int J Health Plann Manage. 2012 Jan-Mar;27(1):34–49.</Citation><ArticleIdList><ArticleId IdType="pubmed">20603842</ArticleId></ArticleIdList></Reference><Reference><Citation>Creese AL, Henderson RH. Cost-benefit analysis and immunisation programmes in developing countries. Bull World Health Organ. 1980;58(3):491–497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2395923</ArticleId><ArticleId IdType="pubmed">6774825</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO/Europe Poliomyelitis (polio) and the vaccines used to eradicate it - questions and answers. Accessed June 28, 2021.</Citation></Reference><Reference><Citation>World Health Organization Poliomyelitis vaccination coverage. 2021. Accessed April 29, 2022.</Citation></Reference><Reference><Citation>Mbabazi W, Lako AK, Ngemera D, Laku R, Yehia M, Nshakira N. Maiden immunisation coverage survey in the republic of South Sudan: a cross-sectional study providing baselines for future performance measurement. Pan Afr Med J. 2013 Nov 23;16:110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4033584</ArticleId><ArticleId IdType="pubmed">24876899</ArticleId></ArticleIdList></Reference><Reference><Citation>Abuagla A, Yousif N, Badr E. Understanding the labour market of human resources for health in sudan. 2013.</Citation></Reference><Reference><Citation>Grundy J, Biggs BA. The impact of conflict on immunisation coverage in 16 countries. Int J Heal Policy Manag. 2019;8(4):211–221.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6499911</ArticleId><ArticleId IdType="pubmed">31050966</ArticleId></ArticleIdList></Reference><Reference><Citation>Nnadi C, Etsano A, Uba B, Ohuabunwo C, Melton M, Wa Nganda G, et al. Approaches to vaccination among populations in areas of conflict. J Infect Dis. 2017 Jul 1;216(suppl_1):S368–S372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5754212</ArticleId><ArticleId IdType="pubmed">28838202</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato R. Effect of armed conflict on vaccination: evidence from the Boko haram insurgency in northeastern Nigeria. Confl Health. 2019 Oct 29;13:49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6819527</ArticleId><ArticleId IdType="pubmed">31673285</ArticleId></ArticleIdList></Reference><Reference><Citation>Mashal T, Nakamura K, Kizuki M, Seino K, Takano T. Impact of conflict on infant immunisation coverage in Afghanistan: a countrywide study 2000-2003. Int J Health Geogr. 2007 Jun 7;6:23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1899486</ArticleId><ArticleId IdType="pubmed">17555557</ArticleId></ArticleIdList></Reference><Reference><Citation>MOH SS. AFP surveillance update South Sudan week 10. 2021.</Citation></Reference><Reference><Citation>Mbaeyi C, Kamadjeu R, Mahamud A, Webeck J, Ehrhardt D, Mulugeta A. Progress towards polio eradication-Somalia, 1998-2013. J Infect Dis. 2014 Nov 1;210(Suppl 1(01)):S173–80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4703039</ArticleId><ArticleId IdType="pubmed">25316833</ArticleId></ArticleIdList></Reference><Reference><Citation>Manyanga D, Byabamazima C, Masvikeni B, Daniel F. Assessment of acute flaccid paralysis surveillance performance in East and Southern African countries 2012-2019. Pan Afr Med J. 2020 Jun 8;36:71.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7380870</ArticleId><ArticleId IdType="pubmed">32754298</ArticleId></ArticleIdList></Reference><Reference><Citation>Morales M, Tangermann RH, Wassilak SGF. Progress toward polio eradication-Worldwide, 2015-2016. MMWR Morb Mortal Wkly Rep. 2016 May 13;65(18):470–3.</Citation><ArticleIdList><ArticleId IdType="pubmed">27171208</ArticleId></ArticleIdList></Reference><Reference><Citation>Bigna JJR. Polio eradication efforts in regions of geopolitical strife: the Boko Haram threat to efforts in sub-Saharan Africa. Afr Heal Sci. 2016;16(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4994566</ArticleId><ArticleId IdType="pubmed">27605975</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassey E, Akpan GU, Okocha-ejeko A. Assessment of the quality of the reverse cold chain management in the Acute Flaccid Paralysis (AFP) surveillance system for polio eradication; South-south Zone, Nigeria 2015. American Journal of Epidemiology and Infectious Disease. 2016;4(5):100–104.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>